Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
Changjiang Yang,
Long Zhao,
Yilin Lin,
Shan Wang,
Yingjiang Ye,
Zhanlong Shen
Affiliations
Changjiang Yang
Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing 100044, China
Long Zhao
Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing 100044, China
Yilin Lin
Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing 100044, China
Shan Wang
Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing 100044, China
Yingjiang Ye
Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing 100044, China
Zhanlong Shen
Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing 100044, China
